R
Robert Tibshirani
Researcher at Stanford University
Publications - 620
Citations - 359457
Robert Tibshirani is an academic researcher from Stanford University. The author has contributed to research in topics: Lasso (statistics) & Gene expression profiling. The author has an hindex of 147, co-authored 593 publications receiving 326580 citations. Previous affiliations of Robert Tibshirani include University of Toronto & University of California.
Papers
More filters
Journal ArticleDOI
Fast Numerical Optimization for Genome Sequencing Data in Population Biobanks.
Ruilin Li,Christopher C. Chang,Yosuke Tanigawa,Balasubramanian Narasimhan,Trevor Hastie,Robert Tibshirani,Manuel A. Rivas +6 more
TL;DR: In this article, Ravi et al. developed two efficient solvers for optimization problems arising from large-scale regularized regressions on millions of genetic variants sequenced from hundreds of thousands of individuals.
Journal ArticleDOI
Discussions of boosting papers, and rejoinders
Peter L. Bartlett,Peter J. Bickel,Peter Bühlmann,Yoav Freund,Jerome H. Friedman,Trevor Hastie,Wenxin Jiang,Michael J. Jordan,Vladimir Koltchinskii,Gábor Lugosi,Jon McAuliffe,Ya'acov Ritov,Saharan Rosset,Robert E. Schapire,Robert Tibshirani,Nicolas Vayatis,Bin Yu,Tong Zhang,Ji Zhu +18 more
TL;DR: In this article, Jiang et al. discuss process consistency for AdaBoost and the Bayes-risk consistency of regularized boosting methods, including convex risk minimization, and statistical behavior and consistency of classification methods.
Journal ArticleDOI
[The ∏ Method for Estimating Multivariate Functions from Noisy Data]: Discussion
Trevor Hastie,Robert Tibshirani +1 more
Journal ArticleDOI
Physicians' warnings for unfit drivers and risk of road crashes.
Journal ArticleDOI
Preliminary Report on a Phase I/II Study of Intratumoral Injection of PF-3512676 (CpG 7909), a TLR9 Agonist, Combined with Radiation in Recurrent Low-Grade Lymphomas.
Wei Yun Z. Ai,Youn H. Kim,Richard T. Hoppe,Sumit A. Shah,Sandra J. Horning,Robert Tibshirani,Ronald Levy +6 more
TL;DR: Intra-tumoral injection of PF-3512676 (CpG 7909), at a fixed dose of 6mg, combined with low-dose radiation (2Gy x 2) is a safe and well tolerated regimen in patients with recurrent low-grade lymphomas, and an anti-Tumor effect has been observed.